IDEX CorporationUnderperforming organic revenue, annual EPS growth of just 1.2% over two years, and eroding returns on capital.
StockStory highlights Natera as a cash-producing stock with exciting potential, while advising investors to avoid Domino’s and IDEX. Natera, which develops genetic tests, saw tests processed grow 19.4% annually over two years, its adjusted operating margin expand by 15.7 percentage points, and free cash flow turn positive over five years. Domino’s is flagged for soft sales growth of 5.2% over seven years and an estimated 5.9% for the next 12 months, trading at 15.3 times forward earnings. IDEX is criticized for underperforming organic revenue, annual EPS growth of just 1.2% over two years, and eroding returns on capital, with shares at 25.2 times forward earnings.
IDEX CorporationUnderperforming organic revenue, annual EPS growth of just 1.2% over two years, and eroding returns on capital.
Natera IncTests processed grew 19.4% annually over two years, adjusted operating margin expanded, and free cash flow turned positive.
Domino's Pizza Inc Common StockSoft sales growth of 5.2% over seven years and estimated 5.9% for next 12 months.